Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System ((JJ-TRAILS))

22 lipca 2019 zaktualizowane przez: Michael L. Dennis, Ph.D., Chestnut Health Systems

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System: Multi-site Implementation Study

This is a multi site experiment to evaluate the impact of various strategies for increasing the use of evidence based screening, assessment and linkage to substance use treatment. All sites collect baseline data and receive a core intervention. Half are then randomly assigned to get an additional year of coaching to facilitate implementation.

Przegląd badań

Status

Zakończony

Warunki

Interwencja / Leczenie

Szczegółowy opis

Background: The Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS) study is a cooperative implementation science initiative involving the National Institute on Drug Abuse, six Research Centers, a Coordinating Center, and Juvenile Justice Partners representing seven U.S. states. The pooling of resources across Centers enables a robust implementation study design involving 36 juvenile justice agencies and their behavioral health partner agencies, coproducing a study protocol that has potential to advance implementation science, meets the needs of all constituencies (funding agency, researchers, partners, study sites), and can be implemented with fidelity across the cooperative can be challenging.

Methods/design: The JJ-TRIALS primary study uses a head-to-head cluster randomized trial with a phased rollout to evaluate the differential effectiveness of two conditions (Core and Enhanced) in 36 sites located in 7 states. Core strategies for promoting change are compared to an Enhanced strategy that incorporate all core strategies plus active facilitation. Target outcomes include improvements in evidence-based screening, assessment, and linkage to substance use treatment.

Primary Research Questions:

  1. Does the Core and/or Enhanced Intervention reduce unmet need by increasing Cascade retention related to screening, assessment, treatment initiation, engagement and continuing care?
  2. Does the addition of the Enhanced Intervention components further increase the percentage of youth retained in the Cascade relative to the Core components?
  3. Does the addition of the Enhanced Intervention components improve service quality relative to Core sites?
  4. Do staff perceptions of the value of best practices increase over time, and are increases more pronounced in Enhanced sites?

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

839

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

  • Stany Zjednoczone
    • Georgia
      • Atlanta, Georgia, Stany Zjednoczone, 30322
        • Emory University
    • Illinois
      • Bloomington, Illinois, Stany Zjednoczone, 61701
        • Chestnut Health Systems
    • Kentucky
      • Lexington, Kentucky, Stany Zjednoczone, 40508
        • University of Kentucky
    • Maryland
      • Rockville, Maryland, Stany Zjednoczone, 20892
        • National Institute on Drug Abuse
    • Mississippi
      • Starkville, Mississippi, Stany Zjednoczone, 39759
        • Mississippi State University
    • New York
      • New York, New York, Stany Zjednoczone, 10032
        • Columbia University
    • Pennsylvania
      • Philadelphia, Pennsylvania, Stany Zjednoczone, 19122
        • Temple University
    • Texas
      • Fort Worth, Texas, Stany Zjednoczone, 76129
        • Texas Christian University

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dziecko
  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Specific site inclusion criteria include: (a) ability to provide youth service records, (b) service to youth under community supervision, (c) access to treatment provider(s) if treatment is not provided directly by the JJ agency, (d) participation in requisite intervention training/activities,(e) minimum average case flow of 10 youth per month, (f) minimum of 10 staff per site, and (g) a senior JJ staff member who agrees to serve as site leader/liaison during the study. Study sites are geographically dispersed and were identified by state JJ agencies (and not selected for particular substance use or related BH service needs).

Youth inclusion criteria include: all youth entering the juvenile justice system during the period within the exception of those who are already in treatment at the time that they are referred to the juvenile justice agency.

Staff inclusion criteria include: all staff actively working with the youth under community supervision in the site with exclusion only of higher level administrative or regional staff over multiple units..

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Badania usług zdrowotnych
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Potroić

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Brak interwencji: Control
During the Baseline Control data is collected in all 36 sites at the agency, staff, and youth level on the 6 months prior to the interventions in Arms 2 & 3 to document what practice was before the study.
Aktywny komparator: Core

In the second phase (after baseline) all 36 sites receive a Core condition that includes five interventions: (1) JJ-TRIALS Orientation Meetings, (2) Needs Assessment, (3) Behavioral Health Training, (4) Site Feedback Report, (5) Goal Achievement Training, (6) Monthly Site Check-ins, and (7) Quarterly Reports. As part of Goal Achievement Training, sites receive assistance in using their Site Feedback Reports to select goals to meet their local needs. Sites are trained on using Data-Driven Decision Making (DDDM) to inform decisions (e.g., selecting a goal, monitoring progress) and enlisting DDDM templates and tools (developed as part of the project) to plan and implement proposed changes.

these principles to their improvement efforts during the implementation phase.
Behawioralne: Core
Inne nazwy:
  • GAT, DDDM
Eksperymentalny: Enhanced
While the core intervention and DDDM are expected to facilitate change, organizations may need additional support to apply these principles to their improvement efforts during the implementation phase. In the third phase (after Core), 1/2 of the sites are randomly assigned to an Enhanced condition that provides continuing support for the use of DDDM tools by adding research staff facilitation of DDDM over a 12-month period and formalized Local Change Teams (LCTs) featuring representation from the JJ agency and a local BH provider, with meetings facilitated by research staff).
Behawioralne: Core
Inne nazwy:
  • GAT, DDDM
Behawioralne: Enhanced
Inne nazwy:
  • DDDM, Facilitation

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Service Cascade: % Referred to Substance Use Treatment
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth referred to substance use treatment divided by the number of youth identified as need of substance use treatment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Treatment
Ramy czasowe: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use treatment services.
120 weeks

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Service Cascade: % Screened for Substance Use Problems
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Screened" for substance use problems divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % Clinically Assessed for Substance Use Problems
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Clinically Assessed" for substance use problems divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % In Need of Substance Use Treatment
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth identified (via screening, clinical assessment or other sources) as "In Need of Substance Use Treatment" divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % Initiating Substance Use Treatment
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Initiating" Substance Use Treatment within 90 days of referral" divided by the number referred to treatment from the juvenile justice system.
120 weeks
Service Cascade: % Engaged in Substance Use Treatment
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Engaged" in Substance Use Treatment for 6 weeks or more weeks divided by the number initiating treatment.
120 weeks
Service Cascade: % With Substance Use Treatment Continuing Care
Ramy czasowe: 120 weeks
number of youth "Continuing" to receive substance use treatment services forCalculated from juvenile justice and substance use treatment agency records as the 90 days or more divided by the number initiating treatment.
120 weeks
Service Quality: Timing of Screening or Clinical Assessment
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the mean days from entry into the justice system to the first of screening or clinical assessment for substance use problems.
120 weeks
Service Quality: Timing of Substance Use Treatment Initiation
Ramy czasowe: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the mean days from referral to and initiation of substance use treatment.
120 weeks
Service Quality: Number of Evidence Based Practices
Ramy czasowe: 120 Weeks
Based on agency surveys and youth records from juvenile justice and substance use treatment agencies, the number of steps using 1 or more evidenced based practices in each of the following steps along the service cascade: screening, clinical assessment, referral, substance use treatment.
120 Weeks
Staff Perception: Value of Evidenced Based Screening
Ramy czasowe: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based screening.
120 weeks
Staff Perception: Value of Evidenced Based Clinical Assessment
Ramy czasowe: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based clinical assessment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Prevention
Ramy czasowe: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use prevention.
120 weeks
Staff Perception: Value of Evidenced Based HIV Risk Prevention
Ramy czasowe: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based HIV Risk prevention.
120 weeks

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Chestnut Health Systems

Współpracownicy

National Institute on Drug Abuse (NIDA)
Texas Christian University
Columbia University
Emory University
Temple University
University of Kentucky
Mississippi State University

Śledczy

  • Główny śledczy: Christy K Scott, Ph.D., Chestnut Health Systems
  • Główny śledczy: Danica K Knight, Ph.D., Texas Christian University
  • Główny śledczy: Michael L Dennis, Ph.D., Chestnut Health Systems
  • Główny śledczy: Tisha R Wiley, Ph.D., National Institute on Drug Abuse (NIDA)
  • Główny śledczy: Gail A Wasserman, Ph.D., Columbia University
  • Główny śledczy: Ralph DiClemente, Ph.D., Emory University
  • Główny śledczy: Gene H Brody, Ph.D., Emory University
  • Główny śledczy: Angela A Robertson, Ph.D., Mississippi State University
  • Główny śledczy: Steven R Belenko, Ph.D., Temple University
  • Główny śledczy: Carl G Leukefeld, Ph.D., University of Kentucky

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Publikacje ogólne

Przydatne linki

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

1 lipca 2013

Zakończenie podstawowe (Rzeczywisty)

31 stycznia 2019

Ukończenie studiów (Rzeczywisty)

30 czerwca 2019

Daty rejestracji na studia

Pierwszy przesłany

22 stycznia 2016

Pierwszy przesłany, który spełnia kryteria kontroli jakości

29 stycznia 2016

Pierwszy wysłany (Oszacować)

3 lutego 2016

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

23 lipca 2019

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

22 lipca 2019

Ostatnia weryfikacja

1 lipca 2019

Więcej informacji

Terminy związane z tym badaniem

Słowa kluczowe

Dodatkowe istotne warunki MeSH

Inne numery identyfikacyjne badania

  • JJ-TRIALS
  • U01DA036221 (Grant/umowa NIH USA)
  • U01DA036226 (Grant/umowa NIH USA)
  • U01DA036233 (Grant/umowa NIH USA)
  • U01DA036176 (Grant/umowa NIH USA)
  • U01DA036225 (Grant/umowa NIH USA)
  • U01DA036224 (Grant/umowa NIH USA)
  • U01DA036158 (Grant/umowa NIH USA)

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

The coordinating center is charged with creating de-identified versions of agency, staff and client level service data available at the end of the study.

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj